DIVA Laboratories, Ltd. engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. The company provides endo/surgical displays for hybrid and other types of OR applications; color and mono displays for radiology applications; and touch and embedded display, as well as industrial displays. DIVA Laboratories, Ltd. was founded in 1984 and is headquartered in New Taipei City, Taiwan.
Frequently asked questions
What sector does DIVA Laboratories Ltd (4153) operate in?
DIVA Laboratories Ltd belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is DIVA Laboratories Ltd (4153) current stock price?
As of the latest data, DIVA Laboratories Ltd stock price is NT$32.80, with a previous close of NT$32.80.
What is DIVA Laboratories Ltd (4153) current market capitalization?
DIVA Laboratories Ltd market cap is approximately 1.92 billion.
What is DIVA Laboratories Ltd (4153) Earnings Per Share (EPS)?
The trailing EPS is NT$1.54.
What is DIVA Laboratories Ltd (4153) Price-to-Earnings (P/E) ratio?
DIVA Laboratories Ltd current P/E ratio is 21.3.
Does DIVA Laboratories Ltd (4153) pay dividends?
Yes. DIVA Laboratories Ltd pays annual dividends with an annualized yield of 6.1% and an estimated annual payout of NT$2.00 per share.
When is the next ex-dividend date for DIVA Laboratories Ltd (4153)?
The next ex-dividend date is scheduled for June 12, 2027.
What is DIVA Laboratories Ltd (4153) beta (volatility) score?
DIVA Laboratories Ltd has a beta of 0.170, indicating lower volatility than the overall market.